MarketCap
Facebook
X
TelegramQuarterly report 2024-Q2
added 08-07-2024
Alimera Sciences Operating Cycle 2011-2026 | ALIM
Annual Operating Cycle Alimera Sciences
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 181 | 229 | 253 | 268 | 207 | 322 | 276 | 217 | 481 | 476 | 447 | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 481 | 181 | 305 |
Quarterly Operating Cycle Alimera Sciences
| 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 188 | 192 | - | 149 | 192 | - | 105 | 110 | 285 | - | 242 | 188 | 290 | - | 289 | 325 | 213 | - | 218 | 271 | 238 | - | 369 | 387 | 134 | 114 | 107 | 101 | 174 | 118 | 152 | 132 | 186 | 154 | 130 | 155 | 123 | 44.5 | 32.2 | 35.4 | 29.6 | - | 60.2 | 255 | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 387 | 29.6 | 175 |
Operating Cycle of other stocks in the Drug manufacturers industry
| Issuer | Operating Cycle | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Assertio Holdings
ASRT
|
590 | $ 18.03 | 0.06 % | $ 115 M |  USA |
 |
Agile Therapeutics
AGRX
|
146 | - | 10.11 % | $ 58.2 M | USA |
 |
AcelRx Pharmaceuticals
ACRX
|
16.5 | - | 7.5 % | $ 6.35 M | USA |
 |
Adamis Pharmaceuticals Corporation
ADMP
|
121 | - | 0.86 % | $ 117 M | USA |
 |
Aerie Pharmaceuticals
AERI
|
576 | - | - | $ 754 M | USA |
 |
Catalent
CTLT
|
152 | - | - | $ 11.5 B | USA |
 |
DURECT Corporation
DRRX
|
560 | - | - | $ 50.1 M | USA |
 |
Athenex
ATNX
|
247 | - | -23.39 % | $ 1.76 M | USA |
 |
Eagle Pharmaceuticals
EGRX
|
214 | - | -39.89 % | $ 27.7 M | USA |
 |
Endo International plc
ENDP
|
180 | - | - | $ 28.9 M |  Irlanda |
 |
Avadel Pharmaceuticals plc
AVDL
|
416 | - | - | $ 2.06 B |  France |
 |
Evoke Pharma
EVOK
|
45.7 | - | - | $ 36.6 M | USA |
 |
Cumberland Pharmaceuticals
CPIX
|
614 | $ 3.26 | 5.5 % | $ 45.8 M | USA |
 |
Cronos Group
CRON
|
425 | $ 2.57 | -0.39 % | $ 1.33 B |  Canada |
 |
HEXO Corp.
HEXO
|
775 | - | 2.45 % | $ 38.1 M | Canada |
 |
Bausch Health Companies
BHC
|
78.9 | $ 5.64 | 0.45 % | $ 2.06 B | Canada |
 |
Harrow Health
HROW
|
217 | $ 36.64 | 1.98 % | $ 1.35 B | USA |
 |
Aurora Cannabis
ACB
|
1.45 K | $ 3.36 | -2.04 % | $ 86.3 M | Canada |
 |
Canopy Growth Corporation
CGC
|
230 | $ 1.03 | -1.43 % | $ 111 M | Canada |
 |
OrganiGram Holdings
OGI
|
2.92 K | $ 1.4 | -0.36 % | $ 402 M | Canada |
 |
Jupiter Wellness
JUPW
|
112 | - | - | $ 33.6 M | USA |
 |
Lannett Company
LCI
|
210 | - | 1.15 % | $ 7.11 M | USA |
 |
Evolus
EOLS
|
134 | $ 4.35 | 1.76 % | $ 280 M | USA |
 |
Emergent BioSolutions
EBS
|
237 | $ 8.0 | 0.5 % | $ 410 M | USA |
 |
Tilray
TLRY
|
222 | $ 6.49 | -1.29 % | $ 4.01 B | Canada |
 |
Organogenesis Holdings
ORGO
|
159 | $ 2.37 | -0.35 % | $ 312 M | USA |
 |
Pacira BioSciences
PCRX
|
246 | $ 24.3 | 2.14 % | $ 1.12 B | USA |
 |
PetIQ
PETQ
|
108 | - | 1.64 % | $ 400 M | USA |
 |
Veru
VERU
|
271 | $ 2.42 | 1.68 % | $ 326 M | USA |
 |
Viatris
VTRS
|
219 | $ 13.53 | 0.45 % | $ 16.2 B | USA |
 |
ProPhase Labs
PRPH
|
141 | - | - | $ 5.07 M | USA |
 |
cbdMD
YCBD
|
176 | $ 0.7 | 4.36 % | $ 3.02 M | USA |
 |
Radius Health
RDUS
|
220 | - | - | $ 1.42 B | USA |
 |
Recro Pharma
REPH
|
112 | - | -4.76 % | $ 65.3 M | USA |
 |
OptiNose
OPTN
|
508 | - | - | $ 1.08 B | USA |
 |
SCYNEXIS
SCYX
|
106 | $ 1.02 | 2.0 % | $ 50.9 M | USA |
 |
PLx Pharma
PLXP
|
111 | - | -27.8 % | $ 2.56 M | USA |
 |
Sonoma Pharmaceuticals
SNOA
|
182 | $ 2.36 | 3.51 % | $ 2.93 M | USA |
 |
Zomedica Corp.
ZOM
|
218 | - | -0.21 % | $ 98 M | USA |
 |
Rockwell Medical
RMTI
|
72.5 | $ 0.91 | 0.02 % | $ 32.7 M | USA |
 |
China Pharma Holdings
CPHI
|
187 | $ 0.65 | 3.14 % | $ 2.79 M |  China |
 |
TherapeuticsMD
TXMD
|
3.34 K | $ 2.03 | -1.93 % | $ 23.5 M | USA |